Bruker (BRKR) Other financing activities (2010 - 2026)
Bruker (BRKR) posted Other financing activities of -$5.0 million for Q1 2026, up 46.81% on a QoQ basis from -$9.4 million in Q4 2025, and down 614.29% year-over-year from $972222.2 in Q1 2025.
Bruker (BRKR) Other financing activities (2010 - 2026) Analysis & Trends
Bruker's Other financing activities history runs 12 years deep, the most recent figure standing at -$5.0 million for Q1 2026.
- Quarterly Other financing activities fell 614.29% year-over-year to -$5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.6 million (up 37.0% YoY) and the FY2025 annual result came in at -$8.3 million, up 66.67% from the prior year.
- Other financing activities was -$5.0 million for Q1 2026 at Bruker, up from -$9.4 million in the prior quarter.
- Across five years, Other financing activities topped out at $10.6 million in Q4 2022 and bottomed at -$17.0 million in Q4 2024.
- A 5-year average of -$2.5 million and a median of -$3.2 million in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities slumped 5766.67% — and 2025, when it jumped 822.22%.
- Bruker's Other financing activities stood at $10.6 million in 2022, then tumbled by 97.17% to $300000.0 in 2023, then slumped by 5766.67% to -$17.0 million in 2024, then surged by 44.71% to -$9.4 million in 2025, then surged by 46.81% to -$5.0 million in 2026.
- Business Quant data shows BRKR's Other financing activities at -$5.0 million in Q1 2026, -$9.4 million in Q4 2025, and $6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.00 Mn |
| Mar 31, 2026 | -5.00 Mn |
| Dec 31, 2025 | -9.40 Mn |
| Dec 31, 2025 | -9.40 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | -4.70 Mn |
| Jun 30, 2025 | -4.70 Mn |
| Mar 31, 2025 | -700,000.00 |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2024 | -17.00 Mn |
| Dec 31, 2024 | -17.00 Mn |
| Sep 30, 2024 | -900,000.00 |
| Sep 30, 2024 | -900,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -5.60 Mn |
| Mar 31, 2024 | -5.60 Mn |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |